Tags : Parkwalk Advisors

Original

Cambridge GaN Devices secures £6.8 million Series A investment co-led

Cambridge GaN Devices raises $9.5m Series A to accelerate the deployment of energy efficient devices reshaping the future of power electronics Cambridge University spinout’s latest funding round will be used to double staff and expand its GaN product portfolio following decades of research in power devices Cambridge, 18th February 2021 – Cambridge GaN Devices (CGD) has raised […]Read More

Pre-Seed

Charco Neurotech secures £500k Seed investment led by Parkwalk Advisors

Imperial College fund makes first investment into tech startup tackling Parkinson’s disease The Imperial College Innovation Fund is managed by leading university spinout fund manager Parkwalk London, 3 February 2020: The Imperial College Innovation Fund (ICIF), an early-stage investment fund launched at Imperial in early 2020 and managed by Parkwalk Advisors to invest in early-stage, high-growth, knowledge-intensive companies, has completed its first investment […]Read More

Seed

Phasecraft secures £3.7 million Seed investment led by LocalGlobe

Phasecraft announces largest seed funding round for a UK quantum computing company and new technology breakthroughs LocalGlobe leads £3.7m/$5m round with Episode1 and previous investors UCL Technology Fund and Parkwalk Advisors, bringing total equity and grant funding to over £5.5m Phasecraft significantly brings forward the timeframe to deliver real-world applications of quantum computing  Internationally leading […]Read More

Original

Congenica secures £39 million Series C investment co-led by Tencent

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom – 9 November 2020 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic […]Read More

Series A

Mind Foundry secures £10.4 million Series A investment led by

Oxford, UK – November 9, 2020 Mind Foundry, an Artificial Intelligence (AI) company that spun out of the University of Oxford’s Machine Learning Research Group (MLRG), today announced it has raised an additional $13.6 million in Series A funding led by Aioi Nissay Dowa Insurance Co., Ltd. (ANDI) of the MS&AD Insurance Group and includes funding from existing […]Read More

VAR - Enterprise Software

GeoSpock secures £4.17 million Series A Follow On investment led

GeoSpock attracts an additional $5.4 million in strategic investment to accelerate adoption of its award-winning Database Technology CAMBRIDGE, UK, 2nd October 2020 – GeoSpock, the company reinventing how data is analysed, has announced $5.4m in additional funding to accelerate the development and adoption of the fastest, most scalable database on the market. This strategic investment […]Read More

Wales

Ceryx Medical secures £575k Seed investment led by Development Bank

Ceryx Medical secures £575,000 to continue development of world-first curative therapy for heart failure Funding will see spinout from Universities of Bath and Bristol expand management and technology teams 22 September 2020 – Ceryx Medical, a bioelectronics startup working towards the world’s first curative therapy for heart failure, has secured a £575,000 seed round. The funding, which […]Read More

Original

Symetrica secures £4 million Series C Follow On from Parkwalk

Radiation detection company Symetrica lands £4 million investment to accelerate international growth Southampton University spinout’s devices help military, law enforcement, and emergency services identify radioactive threats 30 July 2020 – Symetrica, a manufacturer of radiation detection products for military and homeland security applications, has closed a £4 million funding round. The round was led by Parkwalk, the leading […]Read More

East of England

Qkine secures £1.5 million Series A investment led by Parkwalk

Qkine secures £1.5M series A funding from leading life science investors to accelerate global scale-up and make key hires to leadership team Cambridge, UK 08 June 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications – today announced the successful closure of a £1.5M series A investment round […]Read More